Once-weekly semaglutide 7.2 mg in adults with obesity | RemedyX Labs Research Library

A research summary of Once-weekly semaglutide 7.2 mg in adults with obesity, covering Semaglutide (RXL-1SM) in the context of randomized controlled trial research. Cited source and RUO context from RemedyX Labs.